Skip to main content
ILYANG PHARMACEUTICAL CO.,LTD logo

ILYANG PHARMACEUTICAL CO.,LTD — Investor Relations & Filings

Ticker · 007570 ISIN · KR7007570005 KO Manufacturing
Open in API
Filings indexed 225 across all filing types
Latest filing 2019-12-27 Regulatory Filings
Country KR South Korea
Listing KO 007570

About ILYANG PHARMACEUTICAL CO.,LTD

https://www.ilyang.co.kr

Ilyang Pharmaceutical, established in 1946, is a research-oriented company that develops and manufactures a diverse portfolio of pharmaceutical products. The company focuses on developing new chemical entities (NCEs) and produces a range of medicines targeting digestive, respiratory, and circulatory system disorders, as well as neoplasms and infectious diseases. Key developments include 'Ilaprazole' (Noltec), a proton pump inhibitor for acid-related disorders, and 'Supect' (Radotinib), a treatment for chronic myeloid leukemia. Its product line also encompasses general drugs, antibiotics, anti-inflammatory agents, nutritional supplements, and well-established consumer health brands like the digestive aid 'NORUMO' and the nutritional drink 'Wonbi-D'.

Recent filings

Filing Released Lang Actions
투자판단관련주요경영사항(특허권 취득)
Regulatory Filings Classification · 95% confidence The document is a regulatory filing from Il-Yang Pharmaceutical regarding the acquisition of a patent for a sustained-release formulation of bethanechol. It follows the standard format for 'Major Management Matters' (투자판단 관련 주요경영사항) in the Korean market, which is a specific type of regulatory disclosure. Since it does not fit into specific categories like M&A, dividends, or board changes, it falls under the general regulatory filing category.
2019-12-27 Korean
분기보고서 (2019.09)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (분기보고서) for the 3rd quarter of 2019 for Ilyang Pharmaceutical Co., Ltd. It contains detailed financial statements, management discussion and analysis, and corporate governance information, which aligns with the definition of an Interim/Quarterly Report (IR). 9M 2019
2019-11-11 Korean
[기재정정]사업보고서 (2018.12)
Annual Report Classification · 100% confidence The document is a 'Business Report' (사업보고서) for the 48th fiscal year of Ilyang Pharmaceutical Co., Ltd. It contains comprehensive financial statements, management discussions, board information, and governance details. Although it is labeled as a 'Correction Report' (정정신고), it is a full-scale annual filing that includes all the substantive financial and operational data required for an annual report. Therefore, it is classified as a 10-K. FY 2018
2019-08-13 Korean
반기보고서 (2019.06)
Interim / Quarterly Report Classification · 100% confidence The document is a '반기보고서' (Semi-Annual Report) for the company '일양약품(주)' (Ilyang Pharm Co., Ltd.) covering the period from 2019-01-01 to 2019-06-30. It contains detailed financial statements, business descriptions, and management analysis, which fits the definition of an Interim/Quarterly Report (IR). H1 2019
2019-08-13 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a '주식등의 대량보유상황보고서' (Report on Large Shareholding), which is a standard regulatory filing in South Korea under the Capital Markets Act. It details the shareholding status, changes in ownership, and collateral agreements of major shareholders (specifically the Chairman and related parties). This type of filing is used to notify the market of significant ownership stakes and is classified as a Major Shareholding Notification.
2019-07-16 Korean
분기보고서 (2019.03)
Interim / Quarterly Report Classification · 100% confidence The document is a '분기보고서' (Quarterly Report) for the 1st quarter of the 49th fiscal year (2019-01-01 to 2019-03-31) for Ilyang Pharmaceutical Co., Ltd. It contains detailed financial statements, business descriptions, and management analysis, which aligns with the definition of an Interim/Quarterly Report (IR). Q1 2019
2019-05-14 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.